Gilead Sciences
American biopharmaceutical company
Gilead Sciences, Inc. is an American biopharmaceutical company that researches, develops, and commercializes drugs. The company focuses primarily on antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.
History
Gilead Sciences was founded in 1987 by Michael L. Riordan, a medical doctor. The company was originally named Oligogen, Inc. and was later renamed Gilead Sciences. Gilead's first product, Vistide (cidofovir), was approved by the U.S. Food and Drug Administration (FDA) in 1996 for the treatment of cytomegalovirus (CMV) retinitis in patients with AIDS.
Products
Gilead Sciences has developed several notable drugs, including:
- Atripla - a combination drug for the treatment of HIV/AIDS.
- Truvada - used for both treatment and pre-exposure prophylaxis (PrEP) of HIV.
- Harvoni - a combination drug for the treatment of hepatitis C.
- Sovaldi - used for the treatment of hepatitis C.
- Remdesivir - an antiviral drug that has been used in the treatment of COVID-19.
Research and Development
Gilead Sciences invests heavily in research and development (R&D) to discover and develop new therapies. The company has a strong focus on antiviral therapies but also explores treatments for other conditions, including oncology and inflammatory diseases.
Acquisitions
Gilead has expanded its portfolio through several key acquisitions:
- Pharmasset - acquired in 2011, which brought the hepatitis C drug Sovaldi into Gilead's portfolio.
- Kite Pharma - acquired in 2017, which added CAR-T cell therapy for cancer treatment to Gilead's offerings.
- Immunomedics - acquired in 2020, which added the breast cancer drug Trodelvy to Gilead's portfolio.
Corporate Governance
Gilead Sciences is headquartered in Foster City, California. The company's CEO is Daniel O'Day, who took over the role in 2019. The company is publicly traded on the NASDAQ under the ticker symbol GILD.
Controversies
Gilead Sciences has faced criticism and legal challenges over the pricing of its drugs, particularly its hepatitis C treatments Sovaldi and Harvoni. The high cost of these drugs has led to debates about drug pricing and access to essential medications.
See also
References
External links
Lua error in mw.title.lua at line 318: bad argument #2 to 'title.new' (unrecognized namespace name 'Portal').
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
